75 related articles for article (PubMed ID: 232339)
1. Enhancement of the antiviral activity of pyrimidine derivatives against mengovirus by visible light.
Tonew E; Kittler L; Hesse G; Schade W
Zentralbl Bakteriol Orig A; 1979 Sep; 244(4):417-26. PubMed ID: 232339
[TBL] [Abstract][Full Text] [Related]
2. Antiviral pyrimidine derivatives: binding with biopolymers and photosensitization.
Tonew E; Löber G
Acta Virol; 1978 Jan; 22(1):45-51. PubMed ID: 25007
[TBL] [Abstract][Full Text] [Related]
3. Antiviral activity of dipyridamole derivatives.
Tonew M; Laass W; Tonew E; Franke R; Goldner H; Zschiesche W
Acta Virol; 1978 Jul; 22(4):287-95. PubMed ID: 29467
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory activity of 2-aminooxazole derivatives against Coxsackie B1 virus in FL cells.
Tonew M; Tonew E
Acta Virol; 1980 May; 24(3):207-14. PubMed ID: 6158853
[TBL] [Abstract][Full Text] [Related]
5. Effects of pyrimidine derivatives on RNA-dependent RNA polymerase of mengovirus-infected Fogh and Lund (FL) cells.
Tonew E; Fahlabusch B
J Gen Virol; 1977 Jan; 34(1):37-45. PubMed ID: 188980
[TBL] [Abstract][Full Text] [Related]
6. [In vitro effectiveness of new antiviral substances. 1. Results of screening studies against selected picornaviruses].
Tonew M; Tonew E
Virologie; 1985; 36(2):103-9. PubMed ID: 2994288
[TBL] [Abstract][Full Text] [Related]
7. [On the biological action of transition metal complexes. 1. The antiviral activity of palladium aminopyridin-complexes (author's transl)].
Tonew M; Tonew E; Schröer HP; Heyn B
Zentralbl Bakteriol A; 1981 Aug; 249(3):296-301. PubMed ID: 6267845
[TBL] [Abstract][Full Text] [Related]
8. Effect of various pyrimidines possessing the 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] moiety, able to mimic natural 2'-deoxyribose, on wild-type and mutant hepatitis B virus replication.
Kumar R; Semaine W; Johar M; Tyrrell DL; Agrawal B
J Med Chem; 2006 Jun; 49(12):3693-700. PubMed ID: 16759112
[TBL] [Abstract][Full Text] [Related]
9. Novel C-6 fluorinated acyclic side chain pyrimidine derivatives: synthesis, (1)H and (13)C NMR conformational studies, and antiviral and cytostatic evaluations.
Prekupec S; Makuc D; Plavec J; Suman L; Kralj M; Pavelić K; Balzarini J; Clercq ED; Mintas M; Raić-Malić S
J Med Chem; 2007 Jun; 50(13):3037-45. PubMed ID: 17539622
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antiviral activity against Coxsackie virus B3 of some novel benzimidazole derivatives.
Cheng J; Xie J; Luo X
Bioorg Med Chem Lett; 2005 Jan; 15(2):267-9. PubMed ID: 15603937
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of non-nucleoside analogs of toyocamycin, sangivamycin, and ++thiosangivamycin: influence of various 7-substituents on antiviral activity.
Renau TE; Wotring LL; Drach JC; Townsend LB
J Med Chem; 1996 Feb; 39(4):873-80. PubMed ID: 8632411
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and antiviral activity evaluation of some new aminoadamantane derivatives. 2.
Kolocouris N; Kolocouris A; Foscolos GB; Fytas G; Neyts J; Padalko E; Balzarini J; Snoeck R; Andrei G; De Clercq E
J Med Chem; 1996 Aug; 39(17):3307-18. PubMed ID: 8765514
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of antiviral hetarylhydrazones in vitro.
Tonew M
Acta Virol; 1981 Mar; 25(2):108-14. PubMed ID: 6166184
[TBL] [Abstract][Full Text] [Related]
14. [On the biological action of transition metal complexes. 3. About the antiviral activity of cis-dichloro diammine platinum (II) (author's transl)].
Tonew E; Tonew M; Heyn B; Schröer HP
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Nov; 250(4):417-24. PubMed ID: 6277096
[TBL] [Abstract][Full Text] [Related]
15. 'In vitro' antiviral activity of neem (Azadirachta indica. A. Juss) leaf extract against group B coxsackieviruses.
Badam L; Joshi SP; Bedekar SS
J Commun Dis; 1999 Jun; 31(2):79-90. PubMed ID: 10810594
[TBL] [Abstract][Full Text] [Related]
16. [Antiviral thiosemicarbazone and related compounds. III. Quantitative relationships between structure and antiviral activity of isantin-beta-isothio-semicarbazone against mengo virus].
Franke R; Labes D; Tonew M; Zschiesche W; Heinisch L
Acta Biol Med Ger; 1975; 34(3):491-9. PubMed ID: 171890
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of pyrazolo[4',3':5,6]pyrano[2,3-d]pyrimidine derivatives for antiviral evaluation.
Shamroukh AH; Zaki ME; Morsy EM; Abdel-Motti FM; Abdel-Megeid FM
Arch Pharm (Weinheim); 2007 May; 340(5):236-43. PubMed ID: 17464958
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and structure-activity relationships of pyrazolo[3,4-d]pyrimidines: a novel class of potent enterovirus inhibitors.
Chern JH; Shia KS; Hsu TA; Tai CL; Lee CC; Lee YC; Chang CS; Tseng SN; Shih SR
Bioorg Med Chem Lett; 2004 May; 14(10):2519-25. PubMed ID: 15109643
[TBL] [Abstract][Full Text] [Related]
19. Antiviral activities of pyrimidine nucleoside analogues: some structure--activity relationships.
Dragún M; Rada B; Novotný L; Beránek J
Acta Virol; 1990 Aug; 34(4):321-9. PubMed ID: 1981442
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antienteroviral activity of a series of novel, oxime ether-containing pyridyl imidazolidinones.
Chern JH; Lee CC; Chang CS; Lee YC; Tai CL; Lin YT; Shia KS; Lee CY; Shih SR
Bioorg Med Chem Lett; 2004 Oct; 14(20):5051-6. PubMed ID: 15380197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
